Lv42
426 积分 2024-03-26 加入
Polymer–lipid hybrid nanoparticles-based paclitaxel and etoposide combinations for the synergistic anticancer efficacy in osteosarcoma
1个月前
已完结
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease
5个月前
已完结
Ginsenoside Ro Targets BCAT1/2 to Suppress Ferroptosis: A Novel Therapeutic Strategy for Ischemic Cardioprotection
11个月前
已完结
Emerging Trends in Small Molecule Inhibitors Targeting Aldosterone Synthase: A New Paradigm in Cardiovascular Disease Treatment
1年前
已完结
Novel pharmacologic approaches in resistant hypertension
1年前
已完结
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
1年前
已完结
Revising the Roles of Aldosterone in Vascular Physiology and Pathophysiology: From Electocortin to Baxdrostat
1年前
已完结
Clinical Pharmacokinetics and Pharmacodynamics of Baxdrostat
1年前
已完结
Baxdrostat for Treatment-Resistant Hypertension
1年前
已完结
Evaluating phase II results of Baxdrostat, an aldosterone synthase inhibitor for hypertension
1年前
已完结
皖公网安备34019202002308
